Calcium channel blockers and β-blockers in relation to Parkinson's disease
To access this article, please choose from the options below
PII: S1353-8020(06)00221-5
doi:10.1016/j.parkreldis.2006.08.011
© 2006 Elsevier Ltd. All rights reserved.
PII: S1353-8020(06)00221-5
doi:10.1016/j.parkreldis.2006.08.011
© 2006 Elsevier Ltd. All rights reserved.